Wild-type p53 activates transcription in vitro
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
The p53 protein is an important determinant in human cancer and regulates the growth of cells in culture. It is known to be a sequence-specific DNA-binding protein with a powerful activation domain, but it has not been established whether it regulates transcription directly. Here we show that intact purified wild-type human and murine p53 proteins strongly activate transcription in vitro. This activation depends on the ability of p53 to bind to a template bearing a p53-binding sequence. By contrast, tumour-derived mutant p53 proteins cannot activate transcription from the template at all, and when complexed to wild-type p53, these mutants block transcriptional activation by the wild-type protein. Moreover, the simian virus 40 large T antigen inhibits wild-type p53 from activating transcription. Our results support a model in which p53 directly activates transcription but this activity can be inhibited by mutant p53 and SV40 large T antigen through interaction with wild-type p53.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The tumor-suppressor protein, p53, plays a central role in the cellular response to UV-induced DNA damage/repair (13).”
From Melanocyte-stimulating hormone directly enhances UV-Induced DNA repair in keratinocytes by a xeroderma pigmentosum group A-dependent mechanism (2010) · cites this paper as [13]
Citations
Cites
p53 Mutations in Human Cancers
Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018
The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
Scheffner, M., Werness, B. A., Huibregtse, J. M., Levine, A. J., & Howley, P. M. (1990) · Cell · doi:10.1016/0092-8674(90)90409-8 · Cited by 3,995
The p53 tumour suppressor gene
Levine, A. J., Momand, J., & Finlay, C. A. (1991) · Nature · doi:10.1038/351453a0 · Cited by 3,788
How eukaryotic transcriptional activators work
Ptashne, M. (1988) · Nature · doi:10.1038/335683a0 · Cited by 1,825
Identification of p53 as a Sequence-Specific DNA-Binding Protein
Kern, S. E., Kinzler, K. W., Bruskin, A., Jarosz, D., Friedman, P., Prives, C., & Vogelstein, B. (1991) · Science · doi:10.1126/science.2047879 · Cited by 1,085
Oncogenic forms of p53 inhibit p53-regulated gene expression
Kern, S., Pietenpol, J., Thiagalingam, S., Seymour, A., Kinzler, K., & Vogelstein, B. (1992) · Science · doi:10.1126/science.1589764 · Cited by 940
p53: oncogene or anti-oncogene?
Lane, D. P., & Benchimol, S. (1990) · Genes & Development · doi:10.1101/gad.4.1.1 · Cited by 795
Presence of a Potent Transcription Activating Sequence in the p53 Protein
Fields, S., & Jang, S. K. (1990) · Science · doi:10.1126/science.2144363 · Cited by 790
Gannon, J. V., Greaves, R., Iggo, R., & Lane, D. P. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb08279.x · Cited by 688
Transcriptional Activation by Wild-Type but Not Transforming Mutants of the p53 Anti-Oncogene
Raycroft, L., Wu, H., & Lozano, G. (1990) · Science · doi:10.1126/science.2144364 · Cited by 619
Research works printed but not linked: 7
- O'Rourke, R. W. et al. Oncogene 5, 1829–1832 (1990).
- Zhu, H., Roy, A. L., Roeder, R. G. & Prywes, R. New Biologist 3, 455–464 (1991).
- Kern, S. E. et al. Oncogene 6, 131–136 (1991).
- Fried, M. & Prives, C. Cancer Cells 4, 1–16 (1986).
- Soussi, T., Caron de Fromentel, C. & May, P. Oncogene 5, 945–952 (1990).
- Murakami, Y., Asano, M., Satake, M. & Ito, Y. Oncogene 5, 5–14 (1990).
- Zambetti, G. P. et al. Genes Dev. (in the press).
Cited by
Items 501–578 of 578
Bogojević, D., Petrović, M., & Mihailović, M. (2002) · Cell Biology International · doi:10.1006/cbir.2001.0827 · Cited by 5
Satyaprakash, A. K., & Mansur, C. P. (2010) · CRC Press eBooks · doi:10.3109/9781420073133-13 · Cited by 3
Bernal, A., Moltó‐Abad, M., Domínguez, D., & Tusell, L. (2018) · Oncotarget · doi:10.18632/oncotarget.25502 · Cited by 6
“SV40LT antigen triggers p53S15 and stabilises p53 protein, but it is suggested that the direct interaction between SV40LT and p53 inhibits its function as a transcription factor [36].”
BackgroundMolecular Staging of Non-Small-Cell Lung Cancer
Chen, Y., & Gandara, D. R. (2006) · Springer eBooks · doi:10.1007/3-540-31040-1_13 · Cited by 3
Levine, A. J., Bargonetti, J., Bond, G. L., Hoh, J. J., Onel, K., Overholtzer, M., Stoffel, A., Teresky, A. K., Walsh, C. A., & Jin, S. (2005) · Springer eBooks · doi:10.1007/0-387-30127-5_1 · Cited by 4
Hill, S. M., Klotz, D. M., & Cohn, C. S. (1996) · Birkhäuser Boston eBooks · doi:10.1007/978-1-4612-4266-6_7 · Cited by 3
Lymphocyte Death, p53, and the Problem of the “Undead” Cell
Harrison, D. J., Howie, S., & Wyllie, A. H. (1995) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-79437-7_9 · Cited by 4
RNAPII: A Specific Target for the Cell Cycle Kinase Complex
Bakó, L., Nuotio, S., Dudits, D., Schell, J., & Koncz, C. (1994) · Results and problems in cell differentiation · doi:10.1007/978-3-540-48037-2_2 · Cited by 4
“Similarly to RB, p53 is also a transcription factor, which binds to specific sequences located upstream of rRNA genes and c-fos (Farmer et al. 1992; Zambetti et al. 1992).”
BackgroundZIEGLER, B. L., Weiß, M., Thoma, S. J., Lamping, C. P., & Fliedner, T. M. (1995) · Stem Cells · doi:10.1002/stem.5530130741 · Cited by 3
Transcriptional repression in normal human keratinocytes by wild-type and mutant p53
Álvarez-Salas, L. M., Velazquez, A., López‐Bayghen, E., Woodworth, C. D., Garrido, E., Gariglio, P., & DiPaolo, J. A. (1995) · Cancer Letters · doi:10.1016/0304-3835(95)03721-8 · Cited by 5
Molecular and Biological Characteristics of Stroma and Tumor Cells in Colorectal Cancer
Gao, J. (2008) · DiVA (Linkoping University) · Cited by 3
Wang, M., Xu, L., Alu, A., Li, P., Liu, J., Chen, S., He, X., Han, X., Li, Y., Pu, Q., et al. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02471-w · Cited by 4
“Potential upstream regulators could include transcription factors activated by the DNA damage response, such as p53 and NF-κ B, 49 or post-transcriptional mechanisms such as mRNA stabilization.”
Mihara, K., lijima, M., Kondo, T., & Namba, M. (1996) · Cell Structure and Function · doi:10.1247/csf.21.111 · Cited by 1
Mutant p53-Driven Tumorigenesis
Terzian, T., & Lozano, G. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3676-8_5 · Cited by 2
Dominant genetic instability and sensitivity to DNA damaging agents in a mammalian cell line
Ryan, A. J., & Johnson, R. T. (1996) · Somatic Cell and Molecular Genetics · doi:10.1007/bf02369908 · Cited by 2
Shadan, F. F., & Villarreal, L. P. (2000) · Virus Genes · doi:10.1023/a:1008184326950 · Cited by 3
Keith, F. J., & Russell, N. H. (1996) · Cancer treatment and research · doi:10.1007/978-1-4613-1261-1_6 · Cited by 3
The molecular genetics of colonic cancer
Augenlicht, L. H. (1998) · Cancer treatment and research · doi:10.1007/978-1-4615-4977-2_13 · Cited by 4
p53: a cellular Achilles' heel revealed
Burley, S. K. (1994) · Structure · doi:10.1016/s0969-2126(94)00079-4 · Cited by 2
Tung, S.-F., Chuang, J., Lin, C., Lai, M., Wu, C., & Lin, Y.-S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.12.7748 · Cited by 2
Potter, J. D., Sellers, T. A., & Rich, S. S. (1995) · Cancer biology and medicine · doi:10.1007/978-94-011-0677-1_3 · Cited by 2
Pathogenesis of Pituitary Adenomas
Levy, A. (2003) · doi:10.1007/978-1-59259-390-3_1 · Cited by 2
Drugging p53 mutants: Recent advances using small-molecule modulation strategies
Lopes, E. A., Monteiro, T. G., & Santos, M. M. M. (2026) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2026.119149 · Cited by 2
The Evolution of Small DNA Viruses of Eukaryotes: Past and Present Considerations
Shadan, F. F., & Villarreal, L. P. (1996) · Springer eBooks · doi:10.1007/978-1-4613-1407-3_15 · Cited by 1
Transcriptional Activation by p53: Mechanisms and Targeted Genes
MacLachlan, T. K., & El‐Deiry, W. S. (2007) · Springer eBooks · doi:10.1007/0-387-30127-5_3 · Cited by 1
Additional Roles of A-MSH/MC1R Signaling in Melanomagenesis Beyond Melanogenesis
Liu, F., Cui, R., & Dong, F. (2013) · Cited by 1
NMR spectroscopy uncovers direct interaction between BAF60A and p53
Han, J., Kim, T.-H., Moon, S., Park, J.-H., Lee, W., Ko, Y., Ryu, K., Yun, J.-H., & Lee, W. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.10.101 · Cited by 1
ATM, RAD50 and p53 in breast cancer
Tommiska, J. (2008) · Helda - University of Helsinki Institutional Repository · Cited by 1
Chapter 5 Molecular biology of prostate cancer
Gao, X., & Honn, K. V. (1999) · Advances in oncobiology/Advances in oncobiology (Print) · doi:10.1016/s1569-254x(99)80006-5 · Cited by 1
P53 Protein Overexpression in a Case of Conjunctival Micro-Invasive Carcinoma
Calzolari, A., Mincione, F., Messerini, L., Parducci, V., Giannelli, E., & Mincione, G. P. (1994) · European Journal of Ophthalmology · doi:10.1177/112067219400400309 · Cited by 1
“p53 is a tumor suppressor gene encoding a 53 kD nuclear phosphoprotein which can bind to DNA and acts as a transcriptional factor (3).”
BackgroundAgarwal, M. L., Taylor, W. R., & Stark, G. R. (1997) · Springer eBooks · doi:10.1007/978-1-4615-5365-6_5 · Cited by 1
A Transgenic Model to Study the Role of Oncogenes and Tumour Suppressor Genes in T-Cell Lymphoma
Blyth, K. (1996) · Enlighten: Theses (The University of Glasgow) · Cited by 1
Translational Research in Lung Cancer
Singh, D. P., Bylund, K. C., & Chen, Y. (2011) · Medical radiology · doi:10.1007/174_2011_296 · Cited by 1
Suppression of Cellular Proliferation Using p53 DNA Recognition Site-Related Oligonucleotides
Ré, R. N., & Cook, J. L. (1996) · The American Journal of the Medical Sciences · doi:10.1097/00000441-199602000-00002 · Cited by 1
Malignant epithelial neoplasms of the large intestine
Walsh, S. V., Sheahan, K. D., & Carey, F. A. (2024) · Wiley eBooks · doi:10.1002/9781119423195.ch38 · Cited by 1
Proteins that Modulate the Rate of RNA Polymerase III Transcription
White, R. J. (1998) · Springer eBooks · doi:10.1007/978-3-662-03518-4_8 · Cited by 1
P53-Mediated Apoptosis: Regulatory and Mechanistic Aspects
Haupt, Y., Rowan, S., Shaulian, E., Gottlieb, E., Yonish-Rouach, E., Vousden, K. H., & Oren, M. (1996) · Springer eBooks · doi:10.1007/978-1-4615-5895-8_5 · Cited by 1
Biophysical and Biochemical Properties of the p53 Protein
Mukhopadhyay, T. K., Maxwell, S. A., & Roth, J. A. (1995) · Molecular biology intelligence unit · doi:10.1007/978-3-662-22275-1_4
Regulation and Modulation of the Function of p53
Mukhopadhyay, T., Maxwell, S. A., & Roth, J. A. (1995) · Molecular biology intelligence unit · doi:10.1007/978-3-662-22275-1_5
Mechanisms of p53-mediated intrinsic and extrinsic tumor suppression
Li, H. (2014) · Figshare
Genetic and Epigenetic Profiling of Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia
Halldórsdóttir, A. M. (2011) · Uppsala University Publications (Uppsala University)
Khar, A., & Pardhasaradhi, B. V. V. (1996) · Journal of Biosciences · doi:10.1007/bf02703209
Mukhopadhyay, T., Maxwell, S. A., & Roth, J. A. (1995) · Molecular biology intelligence unit · doi:10.1007/978-3-662-22275-1_1
DNA damage‐inducible phosphorylation of p53 at Ser20 is required for p53 stabilization
Yang, D., Rhee, B. K., Yim, T. H., Lee, H. J., & Kim, J. (2002) · Korean Journal of Biological Sciences · doi:10.1080/12265071.2002.9647661
The Antibody Response Against P53 in Cancer Patients
Matlashewski, G. (1994) · Springer eBooks · doi:10.1007/978-1-4615-2449-6_1
Mathé, G. (1994) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(94)90046-9
Small molecule inhibitors of Mdm2 E3 ubiquitin ligase activity
Dickens, M. P. (2011) · UPT. Syiah Kuala University Library (Syiah Kuala University)
Shadan, F. F., & Cowsert, L. M. (1994)
Analyse der Expression von Mutanten p53 in normalen und Tumorzellen
Deppert, W. (2000)
Mutagenesis of the p̳53 tumor suppressor gene studied in Saccharomyces cerevisiae
Moshinsky, D. J. (1998) · DSpace@MIT (Massachusetts Institute of Technology)
Structural and Functional Analysis of p53: The Acidic Activation Domain Has
Hulboy, D. L., & Lozano, G. (1994)
Mechanisms of p53-mediated Intrinsic and Extrinsic Tumor Suppression
Selivanova, G., Höglund, P., Piaggio, G., Elena, R., Pereira, T., Wright, A. R., Wadelius, C., & Universitit, U. (2014)
A Drosophila p53 működésének vizsgálata
Éva, B., & Miklós, B. I. (2008)
Momand, J. A., & Sepehrnia, B. (2003) · Humana Press eBooks · doi:10.1385/0-89603-481-x:161
Stochastic modelling of tumorigenesis in p53 deficient transgenic mice
Mao, J. (1997) · Enlighten: Theses (The University of Glasgow)
Li–Fraumeni syndrome and the p53 tumor suppressor pathway
Irwin, M. S., & Malkin, D. M. (2006) · CRC Press eBooks · doi:10.1201/b13439-62
THE ANTmODY RESPONSE AGAINST PS3 IN CANCER PATffiNTS
Matlashewski, G. (1994)
Sarkari, F. (2011) · TSpace (University of Toronto)
Isolan, G. R. (2004) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
p53 and DNA Damage-Induced Apoptosis in Ovarian Tumour Cell Lines
McIlwrath, A. J. (1997) · Enlighten: Theses (The University of Glasgow)
Li, X., Lei, Y., Yu, Y. Y., Zhang, Y., Zhang, W., Shen, H., Tao, C., Wu, F., Huang, S., & Shao, H. (2020) · PubMed
Borsos, B. N., Pantazi, V., Páhi, Z. G., Majoros, H., Újfaludi, Z., Berzsenyi, I., & Pankotai, T. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.02.22.432201
Focal Adhesion Kinase with the Interacting Proteins and Signaling in Cancer
Golubovskaya, V., Beierle, E. A., Hochwald, S. N., Kurenova, E., & Cance, W. G. (2009) · Springer eBooks · doi:10.1007/978-1-4419-0814-8_12
(1997) · Elsevier eBooks · doi:10.1016/b978-012639875-5/50017-0
Faculty Opinions recommendation of Proapoptotic BAX and BAK control multiple initiator caspases.
Shi, Y. (2005) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.1025884.320840
Fuchs, B., Hecker, D., & Scheidtmann, K. H. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.tb20302.x
Translational Research in Lung Cancer
Qiu, H., Cummings, M. A., & Chen, Y. (2022) · Medical radiology · doi:10.1007/174_2022_346
Hijacking mutant p53 abundance
Kabir, M. (2025) · Nature Chemical Biology · doi:10.1038/s41589-025-02054-4
The Impact of Molecular Genetics on Cancer Research
Dulbecco, R. (1993) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-5663-8_1
Modulation de l'autophagie neuronale par la sérine protéase tPA en conditions ischémiques
Thiebaut, A. M. (2019) · theses.fr (ABES) · doi:10.70675/6586c0abz9e4cz455fz95ffzc52ec76397f8 · Cited by 1
Quartin, R. S., & Levine, A. J. (1994) · Springer eBooks · doi:10.1007/978-1-4615-2421-2_36
Metadata
- Authors
- Farmer, G., Bargonetti, J., Zhu, H., Friedman, P., Prywes, R., & Prives, C.
- Affiliations
- Columbia University (US)
- Venue
- Nature
- Published
- 1992-07
- Volume
- 358
- Issue
- 6381
- Pages
- 83-86
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2063158632
- Cited by
- 579
- References
- 29
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 3 · 2023: 1 · 2022: 8 · 2021: 5 · 2020: 8 · 2019: 3 · 2018: 4 · 2017: 1 · 2016: 4 · 2015: 1 · 2014: 6 · 2013: 5 · 2012: 7
- FWCI
- 38.90
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Keywords
- p53, transcriptional activation, wild-type p53, mutant p53, SV40 large T antigen, DNA-binding proteins, tumour suppressor, protein-protein interaction, transcriptional repression
- MeSH terms
- Animals, Antigens, Polyomavirus Transforming, DNA Mutational Analysis, DNA-Binding Proteins, Gene Expression Regulation, HeLa Cells, Humans, Neoplasm Proteins, Promoter Regions, Genetic, Structure-Activity Relationship, Transcription Factors, Transcription, Genetic, Tumor Suppressor Protein p53, Mice, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.